Hormone Replacement Therapy Flashcards
What is the purpose of HRT and how does it work?
- it is given to perimenopausal / menopausal women to alleviate their symptoms
- their symptoms are caused by a decline in oestrogen
- exogenous oestrogen is given to alleviate the symptoms
How is HRT different in women who have a uterus?
- progesterone needs to be given in addition to oestrogen
- progesterone prevents endometrial hyperplasia + endometrial cancer secondary to “unopposed” oestrogen
What are the non-hormonal treatments for menopausal symptoms that may be trialled prior to HRT?
- lifestyle changes
- CBT
- clonidene
- SSRI antidepressants
- venlafaxine (SNRI)
- gabapentin
SNRI = selective serotonin-norepinephrine reuptake inhibitor
How does clonidene work?
- it is an agonist of alpha-2 adrenergic receptors + imidazoline receptors in the brain
- it lowers the BP + reduces HR
When is clonidene used?
- it can be used to relieve the vasomotor symptoms + hot flushes associated with menopause
- particularly where there are contraindications to HRT
- it is also used as an antihypertensive medication
What are the side effects associated with clomidene?
- dry mouth
- headaches
- dizziness
- fatigue
- sudden withdrawal can result in rapid increases in BP + agitation
What advice is given about alternative remedies for menopausal symptoms?
NOT RECOMMENDED
- their safety / efficacy is unclear
- many have significant adverse effects and interact with other medications
What are the 4 indications for HRT?
- replacing hormones in premature ovarian insufficiency (even without symptoms)
- reducing vasomotor symptoms
- improving symptoms such as low mood, poor sleep, decreased libido + joint pain
- reducing the risk of osteoporosis in women < 60
What is the advice given about the risks / benefits of HRT in younger women?
the benefits generally outweigh the risks in women < 60
What are the key benefits of HRT that should be highlighted to the patient?
- improvement of vasomotor symptoms + others (e.g. mood, joint pain, etc.)
- improved quality of life
- reduced risk of osteoporosis / fractures
What are the risks associated with HRT that it is important to make the patient aware of?
Who is more affected by these risks?
- increased risk of breast cancer (particularly with combined HRT)
- increased risk of endometrial cancer
- increased risk of VTE by 2-3x
- increased risk of stroke / coronary artery disease in older women with long-term use
- the risks are more significant in older women
- the risk increases with a longer duration of treatment
Which groups of individuals may not be affected by the risks of HRT?
- the risks are NOT increased in women < 50 compared with other women their age
- there is no risk of endometrial cancer if the woman does not have a uterus
- there is no increased risk of coronary artery disease with oestrogen-only HRT
How can the risk of endometrial cancer / VTE be reduced?
- the risk of endometrial cancer is reduced by adding progesterone in women with a uterus
- the risk of VTE is reduced by using patches rather than pills
What are the contraindications to starting HRT?
- undiagnosed abnormal bleeding
- endometrial hyperplasia / cancer
- breast cancer
- uncontrolled hypertension
- VTE
- active angina / MI
- liver disease
- pregnancy
What 5 things must be assessed prior to starting HRT?
- take a full history to identify any contraindications
- assess family history of oestrogen-dependent cancers + VTE
- BMI and BP
- ensure cervical + breast screening is up to date
- encourage lifestyle changes that will improve symptoms / reduce risks
What are the 3 steps that must be considered when choosing the HRT formulation?
1 - Do they have local or systemic symptoms?
- local - consider topical treatments
- systemic - move to step 2
2 - Do they have a uterus?
- no - use continuous oestrogen only HRT
- yes - use combined HRT (with progesterone) + move to step 3
3 - Have they had a period in the last 12 months?
- yes - use cyclical combined HRT
- no - use continuous combined HRT
What are the 2 options for delivreing systemic oestrogen?
- oral through tablets
- transdermal through patches / gels